AMPLYX PHARMACEUTICALS
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
AMPLYX PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.amplyx.com
Total Employee:
11+
Status:
Active
Contact:
+118583484458
Email Addresses:
[email protected]
Total Funding:
198.37 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint Dyn DNS Dyn Hosting
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pappas Capital
Pappas Capital investment in Series C - Amplyx Pharmaceuticals
Adage Capital Management
Adage Capital Management investment in Series C - Amplyx Pharmaceuticals
Arix Bioscience
Arix Bioscience investment in Series C - Amplyx Pharmaceuticals
Pfizer
Pfizer investment in Series C - Amplyx Pharmaceuticals
BioMed Ventures
BioMed Ventures investment in Series C - Amplyx Pharmaceuticals
RiverVest
RiverVest investment in Series C - Amplyx Pharmaceuticals
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series C - Amplyx Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series C - Amplyx Pharmaceuticals
3×5 Partners
3×5 Partners investment in Series C - Amplyx Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Amplyx Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-08 | Amplyx Pharmaceuticals Expands Executive Leadership Team |
| 2020-02-04 | Amylyx Pharmaceuticals Appoints Jeffrey Trigilio Chief Financial Officer |
Official Site Inspections
http://www.amplyx.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
